Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Fine-tuning alloreactivity aga...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft-<i>versus</i>-host disease

Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft-<i>versus</i>-host disease

Bibliographic Details
Main Authors: Joseph Pidala, Claudio Anasetti
Format: Article
Language:English
Published: Ferrata Storti Foundation 2022-05-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/10646
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://haematologica.org/article/view/10646

Similar Items

  • Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?
    by: Joseph Pidala, et al.
    Published: (2010-04-01)
  • Alloreactivity of virus-specific T cellsPossible implication of graft-versus-host disease and graft-versus-leukemia effects
    by: Shigeo eFuji, et al.
    Published: (2013-10-01)
  • Targeting PKC theta in alloreactivity and graft-versus-host-disease: unanswered questions and therapeutic potential
    by: Crystina eBronk, et al.
    Published: (2012-08-01)
  • The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality
    by: Joseph Pidala, et al.
    Published: (2011-11-01)
  • Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line.
    by: Michael Koldehoff, et al.
    Published: (2018-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs